Review
Published on 12 Dec 2022
Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.939356
- 11,340 views
- 8 citations



